newsfilter
← Latest News
GlobeNewswire·

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Next generation Bria-OTS+ platform demonstrates rapid, potent and durable anti-cancer activity by activating both innate and adaptive immune responses Increased tumor cell cytotoxicity induced by both Bria-BRES+™